MedTrace Logo

Norwegian COgnitive Impairment After STroke (NorCOAST) Study

NCT02650531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 816

Last updated 2022-02-23

No results posted yet for this study

Summary

A prospective observational multicenter study aiming to describe incidence, and identify predictors for development of poststroke dementia (PSD) and mild cognitive impairment (MCI) after stroke

Conditions

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Lars Jacob Stovner, md prof · Norwegian University of Science and Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-10-08
Completion
2018-10-08

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02650531 on ClinicalTrials.gov